ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
OPINION
Immunity to COVID-19 and issues of screening for SARS-Cov-2 antibodies
About authors
Pirogov Russian National Research Medical University, Moscow, Russia
Correspondence should be addressed: Nikolay A. Mayanskiy
Ostrovityanova, 1, Moscow, 117997; moc.liamg@yalokin.yiksnayam
Received: 2020-06-01
Accepted: 2020-06-15
Published online: 2020-06-23
|
This paper briefly presents the known data on the immune response to SARS-CoV-2, and also analyzes the possibilities and limitations of serological testing for antibodies that should be accounted for when planning population studies and interpreting their results.
Keywords: immunity, screening, COVID-19, SARS-CoV-2, antibodies